Don't know if it has been previously released (and posted) but here is some info on their combo study: 1) 12 weeks SVR goal 2) At least 2 arms 950+222, both+SOC (I suspect they would have a placebo arm as well) 3) Should finalize protocol "soon". On treatment data would be released in Q3 (not followup). I got the sense there may possibly be a shorter duration arm that would be followed by the 12 week.
There may have been more info released on the call I'm listening now, if anyone caught anything else please post. EDIT: 3 month animal tox on 222 (doing longer term studies)
Market Data 
Markets 
AI
